← Back to Search

Behavioural Intervention

Intervention Group for Type 1 Diabetes

N/A

Waitlist Available

Led By Sonia Butalia, MD

Research Sponsored by University of Calgary

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up within 2 months of transfer from pediatric care, repeated at 12 months after transfer

Awards & highlights

Study Summary

This trial aims to study how transitioning from pediatric to adult care affects youth with Type 1 Diabetes. They will look at how this transition intervention impacts the health outcomes of the patients and also evaluate the economic

Who is the study for?

This study is for young people with Type 1 Diabetes who are transitioning from pediatric to adult healthcare services. Participants will be compared to a group that did not have the transition intervention.Check my eligibility

What is being tested?

The trial tests if having a 'Transition Coordinator' helps improve health and patient satisfaction during the shift from child to adult diabetes care, including looking at cost-effectiveness.See study design

What are the potential side effects?

Since this trial involves non-medical support rather than medication, traditional side effects like those seen with drugs are not expected.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within 2 months of transfer from pediatric care, repeated at 12 months after transfer

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within 2 months of transfer from pediatric care, repeated at 12 months after transfer

This trial's timeline: 3 weeks for screening, Varies for treatment, and within 2 months of transfer from pediatric care, repeated at 12 months after transfer for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Lost to Followup

Secondary outcome measures

Clinical Outcome 1

Clinical Outcome 2

Clinical Outcome 5

+6 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention GroupExperimental Treatment1 Intervention

Patients in this arm receive access to and support from a Transition coordinator who will meet with them prior to transition from pediatric to adult care and follow up with them every 2 months throughout the first year of their transition period utilizing phone, text, email, social media.

Group II: Usual Care GroupActive Control1 Intervention

No intervention group used as a control leading into the intervention for comparative analysis. Patients in this arm receive care as usual with no changes and are not aware of the intervention group.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Juvenile Diabetes Research FoundationOTHER

232 Previous Clinical Trials

141,460 Total Patients Enrolled

University of CalgaryLead Sponsor

792 Previous Clinical Trials

868,830 Total Patients Enrolled

Canadian Institutes of Health Research (CIHR)OTHER_GOV

1,344 Previous Clinical Trials

26,453,093 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Which individuals meet the criteria for participation in this research investigation?

"To be eligible for participation in this research, individuals must have been diagnosed with type 1 diabetes and fall between the ages of 17 to 18. The study aims to recruit approximately 324 participants."

Answered by AI

Are participants who are older than 80 years of age eligible for enrollment in this medical study?

"Individuals as young as 17 and up to 18 years old are eligible for inclusion in this research."

Answered by AI

Are there currently any available slots for new participants in this medical trial?

"As per the details on clinicaltrials.gov, patient recruitment for this particular trial is presently inactive. The trial was initially listed on April 1st, 2024, with its latest update noted on March 1st, 2024. Despite the current non-recruitment status of this study, it's noteworthy that there are currently 1266 other ongoing trials open to potential participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Diabetes Transition Coordinator Study

2024. "Diabetes Transition Coordinator Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06300047.